Oncology Cell Panel Screening Platform
Screen your compounds across our comprehensive cell screening panel of over 600 authenticated, validated human cancer cell lines covering 50 cancer types. We provide single agent and combination compound screening for potency and synergy, and bioinformatics analysis for mechanistic studies and biomarker discovery related to drug responses. We also offer an extensive KRAS mutant cell line profiling panel and more than 300 ready-to-use CDX models.
Learn more about our extensive panel of cancer cell lines & in vitro oncology assays by clicking HERE.
Oncology cell panel screening platform
Related Content
Strategies to stimulate dendritic cell (DC) activity, such as ex vivo generation and priming of DC vaccines, have been explored...
VIEW RESOURCEVaricella-zoster virus (VZV) is a highly contagious alpha-herpesvirus that infects more than 90% of people worldwide. The primary infection with...
VIEW RESOURCE